Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
nice job noc,
wEa, do you own stock here?
Here is a tip, Raging Bull is run by MM's.
Wall Street Capital Funding LLC: Issues Tuesdays Stocks on the Move! June 20, 2006
http://www.stockhouse.com/news/news.asp?newsid=4165125&tick=XKEM
bellwetherreport.com: The Bellwether Report Issues an Update on Xechem International, Inc
6/21/2006
http://www.stockhouse.com/news/news.asp?newsid=3969941&tick=XKEM
RAGING BULL STILL BROKE
GO XKEM
YYYIIIIIIIIIIIIIIIIIHHHHHHHHHHAAAAAAAAAAAAAAAAAA
XKEM BROKE RAGING BULL
YYYYYYYYYYYYEEEEEEEEEEEEEEEEEEEEEEEEHHHHHHHHHHHAAAAAAAAAAAAAAWWWWWWWWWWWWWWWWW
ARCA:
Archipelago Trading Services, Inc.
NASDAQ TRADING
312-969-1318
OTCBB TRADING
312-442-7700
Think again pal.
This is great, if this was bashing dilution the PPS would be .010, this is financing dilution at its best. CAN'T even get below .028
.05 to .10 on news, WATCH
I am adding today on every pull back , if any.
By: billmoneyi
20 Jun 2006, 08:19 PM EDT
Msg. 52608 of 52749
Jump to msg. #
Read this important............................
Someone on the board was wondering why borrow money from chassman? I have a bacholers in Social Studies and Buisness. The reason is simply that it is quicker to get loans from chassman, rather then the conventional way( Big Banks). There is too much paper work involved in the conventional way of taking loans, which equals delay and longer time. Also why would chassman loan money and get paid back in the form of shares (they know something we dont know). XKEM need money quick for what is coming and are finicialy backing themselves for the future (just in case). You need money to make money. I hope this cleared alot of fear from some of the family on this board.
God Bless
ALL-OR-NONE, just buy that way to get bigger lots, if you can't, then that is a GOOD SIGN.
HUH, flippers ain't flipp'in,
GREAT, all good
Wheres all the sellers, SWEEEET
Great sign.
Shares are drying up, eveybody buying and holding for news, large blocks are lucky to get.
Gee, could MM's be accumulating for appreciation?
;) WHAAAAAAAAAAAAAAAAAAAAAAA
I can't even get 100k shares at .03
GREAT JOB ON IBOX, I have been sending a lot of people here for DDing.
By: royal2007
14 Jun 2006, 08:09 AM EDT
Msg. 47194 of 47209
(This msg. is a reply to 47192 by swim240.)
Jump to msg. #
NAFDAC phone --- 234 09 5240995 / 234 09 5240994 Call investors they answer NICOSAN is APPROVE !
This was a after hours buy on Friday.
Price Size Exch Time
0.0326 470000 OBB 16:09:58
Whee do you think we are going next week?
;)
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
otcstockexchange.com: NHNV, XKEM, IPRE, CTKH OTCStockExchange.com Stock Alert
Rochester, NY, Jun 12, 2006 (M2 PRESSWIRE via COMTEX) -- OTCStockExchange.com's "Stock Watch Alert" this morning are Notch Novelty Corporation (Pink Sheets: NHNV), Xechem International, Inc. (OTCBB: XKEM), Imperia Entertainment, Inc. (Pink Sheets: IPRE), Cetek Technologies Inc. (Pink Sheets: CTKH).
Sign-up for our FREE Stock Alerts at http://www.otcstockexchange.com !
Xechem International, Inc. (OTCBB: XKEM - http://finance.yahoo.com/q?s=XKEM.OB ) Xechem International, Inc. announced that it has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA), Office of Orphan Drug Products Development, for the five-membered heterocyclic anti-sickling compound known as 5-HMF for the treatment of patients suffering from sickle cell disease (SCD).
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
bellwetherreport.com: The Bellwether Report Notices the Change in Inverstors Sentiment for Xechem International, Inc
Jun 12, 2006 (M2 PRESSWIRE via COMTEX) -- Xechem International, Inc (OTCBB:XKEM), is a company that our research team will be tracking over the ensuing weeks. They recently came out with a significant corporate development, causing a market stir. The BWR Research Team will continue to bring its subscribers cutting edge research tools, and second to none customer service.
Xechem International, Inc a development stage biopharmaceutical company whose focus and resources are currently being primarily directed toward the development and commercial launch of NICOSAN, which has shown efficacy in the prophylaxis management of Sickle Cell Disease, during the beginning of this week the company's Nigerian subsidiary, Xechem Pharmaceuticals Nigeria Ltd, successfully closed on a N150 Million Naira ($1.2 million) loan from the Nigerian Export-Import Bank.
The loan has a three year term, with a moratorium on repayment of principal during the first year. Xechem International is neither a borrower nor a guarantor under the loan facility in this transaction.
The money received by Xechem Nigeria is to be used primarily to facilitate the expansion of its facility for the commercial scale production of NICOSAN(TM), its promising Sickle Cell drug.
At the signing ceremony held at NEXIM's headquarters in Abuja, Nigeria, Dr. Ramesh Pandey, Chairman and CEO of both Xechem International and Xechem Nigeria, said, "The loan will enable the company to immediately begin construction of buildings needed to expand its commercial scale production facility in Abuja. It is a proud moment not only for Xechem Nigeria, but for the whole of Nigeria as well.
By taking this giant step with us, NEXIM Bank has confirmed to the world the great confidence it has in this project. This will not only accelerate Xechem's efforts in bringing NICOSAN(TM) to the market, but will also help build international esteem for Nigeria and the changing investment climate in that country. We are extremely gratified that we can now embark on our much needed expansion, and are particularly excited that we can do so with locally generated funds from a respected and reputable local bank."
The Chairman of NEXIM Bank, who is also Deputy Governor of Central Bank of Nigeria, Mr. Tunde Lemo, complimented Xechem for coming to Nigeria and setting up the facility to produce NICOSAN(TM) to treat an African disease for which there is no drug in the market.
Speaking of the dignitaries in attendance at the signing ceremony, Dr. Pandey added: "I am very pleased and happy to see Professor A.B.C. Nwosu, the former Honorable Health Minister, at this ceremony. It was during his tenure that Xechem obtained the exclusive worldwide license for NICOSAN(TM) from the National Institute for Pharmaceutical Research and Development (NIPRD).
I am also honored to see among those in attendance the Hon. Prof. Turner Isoun, Nigeria's Minister of Science and Technology.
From the beginning, he has been extremely supportive of our efforts and we are forever grateful for the interest he has taken in what we are doing in Nigeria."
Xechem International, Inc has enjoyed some fairly exciting trading so far this morning as shares take a bit of a jump, up over 10%. Although this company is trading up significantly there has been know corporate developments to justify this correction, and could be the sign of good things to come. This company has a lot of potential to really enjoy prosperous future, but will have to find away to keep shareholders interested as many have sold off following the company's most recent news release. Currently this company is trading at $0.032 on volume of 19 million shares. The BWR Research Team will continue to follow the market sentiment on this company and numerous others.
To review research on small cap companies like Xechem International, Inc, as well as many more exciting articles we encourage you to visit www.bellwetherreport.com. You can find these reports under the "Today's Articles" section. No credit Card Needed!! The Bellwether Report will continue to research all of the markets to bring you exciting opportunities!! If you are interested in receiving more information on these small or large cap opportunities as well as other features of our site, feel free to sign up for a complimentary subscription to the #1 online investment tool www.bellwetherreport.com.
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
Iron Consulting: www.growthstockanalyst.com , Stocks To Watch: SOEN, ADVC, XKEM, MNCP, HLSH
Jun 12, 2006 (M2 PRESSWIRE via COMTEX) -- Stocks To Watch: Solar EnerTech Corp. (OTCBB: SOEN), Advanced Communications Technologies Inc. (OTCBB: ADVC), Xechem international Inc. (OTCBB: XKEM), Motient Corp. (PinkSheets: MNCP), HealthSouth Corp. (PinkSheets: HLSH)
Ticker Symbol XKEM: Current Price (0.0315) www.growthstockanalyst.com
Xechem International, Inc., a biopharmaceutical company, engages in the research, development, and production of generic and proprietary drugs from natural sources. Its principal product under development is NICOSAN/HEMOXIN, which would be used for the treatment of sickle cell disease. The company also applies its proprietary extraction, isolation, and purification technology to the production and manufacture of Paclitaxel, which is an anti-cancer compound used for the treatment of ovarian, breast, small cell lung cancers, and AIDS-related kaposi sarcomas. In addition, Xechem International engages in the research and development of other compounds using traditional medicinal plants, microbial fermentation, or semisynthesis to produce anti-cancer, anti-fungal, anti-viral, anti-inflammatory, anti-aging, and memory-enhancing compounds. It operates in the United States, India, the People's Republic of China, and Nigeria. The company was founded by Ramesh C. Pandey in 1994. Xechem International is headquartered in New Brunswick, New Jersey.
This was a after hours buy on Friday.
Price Size Exch Time
0.0326 470000 OBB 16:09:58
Whee do you think we are going next week?
;)
N E X T UP .05
This is too funny, REUTERS has a RISK ALERT on XKEM as being "NONE". I always wanted to own stocks with no risk. ;)
http://today.reuters.com/stocks/Overview.aspx?ticker=xkem&fs=1
No one selling, no one dumping, try to fill at .019-.020, NOTHING, THIS IS GOING HUGE.
Let bashers do their own DD, don't answer their stupid questions, there is a reason for the volume in this stock and most of us know why!!!
.20 will come easy.
MM's CAN NOT control this.
I don't think you will see .017-.018 again.
Do you think there will be any action here today? ;)
Look at the reports now:
Report Title Date Provider Pgs Price
Xechem International, Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Special Offer! Get this report FREE (One Per Customer)
This report is essential reading for any serious investor, providing comprehensive financial information on a company's performance,... 30 May 2006 Reuters Investment Profile 11 $20.00
Plunkett's Biotech and Genetics Industry Trends and Statistics 2006 (Summary)
(Published 8/23/2005) This report will be your ready-reference guide to the Biotechnology
and Genetics Industry. In one carefull... 1 Jun 2006 Plunkett Research, Ltd. 50 $99.00
ValuEngine Summary Report for XKEM
Advanced academic research that brings you superior investment strategies in an actionable format. All the facts required for cruc... 22 May 2006 ValuEngine, Inc. 11 $9.00
A textual analysis of Xechem International, Inc's financial statements, including company description and recent stock performance, versus Addison-Davis Diagnostics, Inc., Insite Vision Incorporated and Repros Therapeutics Inc.. 20 May 2006 Wright Reports $25.00
Plunkett's Biotech and Genetics Industry Almanac 2006
(Published 8/23/2005) Plunkett's Biotech & Genetics Industry Almanac is a complete
reference guide to the business side of biote... 17 May 2006 Plunkett Research, Ltd. 583 $299.00
Weiss Stock Report For: XECHEM INTERNATIONAL INC 11 May 2006 Weiss Ratings 5 $25.00
Weiss Stock Report For: XECHEM INTERNATIONAL INC 20 Apr 2006 Weiss Ratings 5 $25.00
XECHEM INTL INC (XKEM=US) 2-weeks forecast
"www.PECHALA.com - This report providing analysis, 2-week forecast, Pechala Power Rating (PPR), relative performance with DJIND, S&P... 16 Apr 2006 Pechala's Reports 1 $10.00
REUTERS gives XKEM a "LOW - RISK ALERT"
with two institutions holding shares now.
http://today.reuters.com/stocks/overview.aspx?ticker=XKEM
BID AND ASK AT .02 ALREADY ON E*TRADE
This is going to be B I G.
The firm already has a Nigerian subsidiary to sell nutraceuticals for sickle cell disease and other conditions in various African nations.
http://www.hoovers.com/xechem/--ID__46688--/free-co-factsheet.xhtml
...the data showed that treatment with Nicosan significantly reduced the frequency of SCD "crises" associated w/severe pain during a six month period.Moreover,73% of patients acieved complete total remission from SCD symptoms